Glutathione Peptide: Is It Actually a Peptide?

A peptide is a chain of amino acids joined by amide bonds. Glutathione has three amino acids joined by two such bonds, which makes it a tripeptide by any definition a biochemist would accept.

The full name is gamma-glutamyl-cysteinyl-glycine. Glutamate sits at one end, cysteine in the middle, glycine at the far end. Cysteine carries the reactive sulfur atom (the thiol, written SH) that does all the chemical work.

The gamma is where glutathione stops behaving like an ordinary peptide. In a normal peptide bond, the amino acid donates its alpha-carboxyl, the one attached to the same carbon as the amine group. Glutamate here donates its side-chain carboxyl instead, five carbons down. PubChem records the IUPAC name as (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid (PubChem CID 124886), and that "5-oxo" position is the gamma-carboxyl doing the linking, with the alpha-carboxyl left free as an acid.

That single structural quirk has a consequence. Ordinary peptidases recognise alpha linkages and slice them. They do not recognise the gamma bond, so glutathione survives inside cells for hours rather than seconds. One enzyme does cleave it: gamma-glutamyl transferase, which sits on the surface of intestinal and liver cells. Witschi's group attributed the negligible systemic availability of swallowed glutathione to exactly that enzyme (Witschi et al., Eur J Clin Pharmacol, 1992, PMID 1362956).

Compare this to two molecules the supplement market keeps miscategorising. NAD+ is a dinucleotide, no amino acids in it. SLU-PP-332 is a small synthetic organic compound. Neither is a peptide. Glutathione is the rare case where the label is chemically correct.

Picture a kitchen sponge. It soaks up a spill, you wring it out over the sink, and it goes back to the counter ready for the next spill. The sponge is never consumed. It cycles between soaked and wrung, and what limits you is how fast you can wring it, not how many sponges you own.

Glutathione cycles the same way. In its reduced form (GSH), the cysteine thiol donates an electron to a reactive oxygen species and neutralises it. Two spent GSH molecules bond together into oxidised glutathione (GSSG). An enzyme called glutathione reductase then strips the bond, spends NADPH, and hands you back two fresh GSH. The literal statement: glutathione is a recyclable redox buffer, and the ratio of GSH to GSSG is the readout of how oxidatively stressed a cell is.

Healthy cells hold that ratio heavily toward the reduced side and maintain glutathione at millimolar concentrations inside the cytosol. Witschi measured basal plasma glutathione at only 6.2 micromol per litre in healthy volunteers. Blood carries a trace. Cells hold the reservoir, and glutathione synthesis is a two-step ATP-dependent reaction whose rate is capped by how much cysteine is available (Forman et al., Mol Aspects Med, 2009, PMID 18796312).

That last clause is the whole strategy. If cysteine is the bottleneck, the sensible intervention is to deliver cysteine, and glutathione is a poor cysteine delivery vehicle because the gut takes it apart before it reaches the bloodstream intact.

Most peptides sold in this space are signalling molecules. They bind a receptor, flip a switch, and a cell changes behaviour. GHK-Cu upregulates collagen genes in fibroblasts. BPC-157 modulates growth factor expression in healing tissue. Their function lives in their shape, which is why a single amino acid substitution can kill the effect.

Glutathione binds no receptor as its primary act. Its function lives in one sulfur atom. Strip away the glutamate and the glycine and you still have a thiol that donates electrons; the two flanking amino acids exist mainly to protect the cysteine from being oxidised or degraded on its own.

So a reader who learns that glutathione is a peptide has learned a fact about bond geometry. They have not learned that it heals tendons, or grows hair, or lightens skin. Those claims each need their own evidence, and they mostly do not have it. If you are new to the category, GHK-Cu benefits shows what a well-evidenced signalling peptide's data actually looks like by comparison.

Here is the mistake. You buy 500 mg oral glutathione capsules, take two daily, and expect your plasma glutathione to climb the way a vitamin C level would.

Witschi gave seven healthy volunteers 0.15 mmol per kilogram of oral glutathione, roughly 3.5 grams for a 75 kg adult, which is seven of those 500 mg capsules in one sitting. Over the following 270 minutes, plasma glutathione, cysteine and glutamate showed no significant rise from a baseline of 6.2, 8.3 and 54 micromol per litre. The conclusion was that systemic availability is negligible in humans (Witschi et al., Eur J Clin Pharmacol, 1992, PMID 1362956).

Allen and Bradley then ran the realistic consumer protocol. Forty healthy adults, 500 mg twice daily, four weeks, randomised and placebo-controlled. No significant change in urinary F2-isoprostanes, no change in 8-hydroxy-2'-deoxyguanosine, no change in erythrocyte glutathione status (Allen & Bradley, J Altern Complement Med, 2011, PMID 21875351).

Run the arithmetic on that protocol. One gram a day for 28 days is 28 grams of glutathione, 56 capsules, and at typical retail pricing between 30 and 60 dollars. The measured return on every oxidative stress biomarker the trial tracked was zero.

The honest complication is duration. Richie's six-month trial at 250 mg and 1,000 mg daily did move body stores: erythrocyte glutathione rose about 17 percent on the low dose, plasma and erythrocyte glutathione rose 30 to 35 percent on the high dose, and buccal cell glutathione climbed 260 percent (Richie et al., Eur J Nutr, 2015, PMID 24791752). Six months at 1,000 mg daily is 180 grams of powder and several hundred dollars for a 30 percent shift in a marker no one has tied to a clinical outcome.

The fix: stop paying for acute plasma effects that trials say do not exist. If you want a six-month, several-hundred-dollar experiment in raising body stores, price it honestly against everything else in your cabinet first. See how much peptides cost.

Clinics across the United States, Southeast Asia and the Gulf sell intravenous glutathione drips marketed for brighter or lighter skin. A typical package runs 10 sessions at 150 to 250 dollars each, so 1,500 to 2,500 dollars, often at 600 to 1,200 mg per infusion once or twice weekly.

The US Food and Drug Administration has approved no injectable drug for skin whitening or lightening. Its consumer update calls these products unapproved new drugs, warns they may contain unknown harmful ingredients or contaminants, and notes that improper injection can transmit disease and cause serious injury (FDA, Injectable Skin Lightening and Skin Bleaching Products May Be Unsafe).

The Philippine Food and Drug Administration went further in a May 2011 advisory, and the adverse events it catalogued are specific: Stevens-Johnson syndrome and toxic epidermal necrolysis, thyroid dysfunction, renal dysfunction, severe abdominal pain, air embolism, and potentially fatal sepsis from unsterile administration. Stevens-Johnson syndrome and toxic epidermal necrolysis involve the epidermis detaching in sheets. Both are dermatologic emergencies managed in burn units.

What are you buying that risk for? Sonthalia's review of the field concluded that clinical evidence for intravenous glutathione as a skin lightener rests on "a single study with a dubious study design" and apparently flawed analysis (Sonthalia et al., Dermatol Pract Concept, 2018, PMID 29445569). Two thousand dollars, one weak trial, and a documented pathway to a burn-unit admission.

This site does not publish an intravenous glutathione protocol, and no reputable source should. Intravenous administration of an unapproved compound for a cosmetic indication sits at the far end of the risk spectrum. Read are peptides legal and the peptide safety guide before any clinic takes your card.

The fix: if hyperpigmentation is the actual problem, that is a dermatology consultation, not an infusion suite.

Four words on a bottle carry almost all the information, and most buyers skim past them.

Reduced glutathione (GSH). The active form, the one with the free thiol. Sometimes printed as "L-glutathione reduced" or under the branded ingredient name Setria. This is what the Witschi, Allen and Richie trials used orally.

Oxidised glutathione (GSSG). Two glutathione molecules already bonded through their sulfurs, meaning the thiols are spent. Your cells can reduce it back, but paying premium prices for the spent form makes no sense. If a label says only "glutathione" with no "reduced," ask the manufacturer which one is in the capsule.

Liposomal. Glutathione wrapped in phospholipid vesicles to survive the gut. Sinha's pilot found 40 percent higher whole blood glutathione, 25 percent higher in erythrocytes and 28 percent higher in plasma after two weeks at 500 to 1,000 mg daily, with natural killer cell cytotoxicity up as much as 400 percent (Sinha et al., Eur J Clin Nutr, 2018, PMID 28853742). Read the fine print: twelve subjects, one month, and the authors disclosed research funding from the company that makes the product. Encouraging at pilot scale. Nowhere near established.

Sublingual. Dissolved under the tongue to bypass first-pass gut and liver metabolism. Schmitt's three-week crossover in 20 people with metabolic syndrome found the sublingual form raised total and reduced plasma glutathione and improved the GSH/GSSG ratio (p=0.003) where standard oral glutathione did not (Schmitt et al., Redox Biol, 2015, PMID 26262996). Twenty subjects gives a signal. It does not settle the question.

Then there is what a serum or plasma glutathione number means when a wellness clinic hands you one. Almost all body glutathione sits inside cells at millimolar concentration; plasma carries single-digit micromolar. A plasma reading is a spillover measurement, several orders of magnitude removed from the intracellular pool that actually matters, and it moves with sample handling, fasting state and how fast the tube reached the lab. A single plasma glutathione value is close to uninterpretable on its own. What researchers track instead is the GSH/GSSG ratio in a controlled specimen.

When you compare vendors, apply the same scrutiny you would to any research chemical purchase. See where to buy peptides in 2026.

Cysteine limits glutathione synthesis. Free cysteine is unstable in solution and mildly toxic at high intakes, so the practical donor is N-acetylcysteine (NAC), a cysteine molecule with an acetyl group protecting the amine.

Sekhar's group tested the precursor logic directly. Elderly subjects with depleted red cell glutathione received cysteine and glycine supplementation for two weeks. Red cell glutathione concentration rose 94.6 percent, the fractional synthesis rate rose 78.8 percent, and plasma oxidative stress markers and F2-isoprostanes fell (Sekhar et al., Am J Clin Nutr, 2011, PMID 21795440). Roughly a doubling of the intracellular pool, from a substrate that survives digestion.

Set that beside 3.5 grams of oral glutathione producing no significant plasma change in 270 minutes. Feeding the factory beats shipping the finished product through an enzyme that exists specifically to dismantle it.

NAC is not free of consequences. It carries a sulfurous smell, can cause nausea and gastrointestinal upset, and interacts with nitrates and some anticoagulant regimens. It is also the standard hospital antidote for paracetamol overdose, precisely because it restores hepatic glutathione, which is about as strong a proof of mechanism as this field offers. Review peptide therapy side effects and talk to a clinician if you take other medication.

One more honest note on the immune claims. Both Richie and Sinha reported large increases in natural killer cell cytotoxicity, which is why glutathione appears in immune-support marketing. Those were small trials with surrogate endpoints and no infection outcomes. For where the immune evidence is stronger, see peptides for the immune system.

One row per delivery route, with what the trial actually measured rather than what the marketing claims.

Nothing in this table describes an injection protocol, and nothing here should be read as one. Dosing decisions belong to a clinician who has seen your labs.

Mistake 1: Assuming "peptide" implies "signalling peptide." Glutathione shares a bond type with BPC-157 and shares nothing else. A shopper who reasons "peptides heal tissue, glutathione is a peptide, therefore glutathione heals tissue" has made a category error. The fix: judge every compound on its own trial data.

Mistake 2: Buying oral glutathione for an acute effect. Two randomised trials found no plasma rise at 3.5 grams and no biomarker change at 1 gram daily for four weeks. Spending 30 to 60 dollars a month on that expectation buys nothing measurable. The fix: use a cysteine precursor, or accept a six-month timeline for modest body-store changes.

Mistake 3: Treating an IV drip as a cosmetic. The FDA approves no injectable skin whitener. The Philippine FDA has documented Stevens-Johnson syndrome, toxic epidermal necrolysis, renal and thyroid dysfunction and air embolism in this exact use case. The fix: see a dermatologist about pigmentation. Nobody's complexion is worth a detached epidermis.

Mistake 4: Reading a single plasma glutathione number as a health score. Plasma holds single-digit micromolar glutathione while cells hold millimolar. The blood value is spillover, sensitive to fasting and sample handling, and one draw tells you almost nothing. The fix: if a clinic sells you a panel on that basis, ask what the GSH/GSSG ratio was and how the specimen was stabilised.